Skip to content

Genpact

US · G #2004 by market cap Listed 1970
41.50 +0.66 +1.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Near fair value
33.88 fair value ≈ 52.11 70.35
  • Implied fair-value range of 33.88-70.35, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -20.4% below the average-multiple fair value of 52.11.

Valuation each multiple against its own 5-year range

P/B ratio 2.69 Cheap vs history 25th percentile
5-year average 3.44 · #48 of 76 in Information Technology Services
P/E ratio 12.71 In line with history 34th percentile
5-year average 16.65 · forward 11.35 · #13 of 40 in Information Technology Services
P/S ratio 1.36 Cheap vs history 24th percentile
5-year average 1.62 · forward 1.27 · #39 of 80 in Information Technology Services

Vs. peers Information Technology Services

Company Market cap P/E (TTM) P/B Div yield
Genpact (G) 6.94B 12.10 2.56 1.77%
IBM Corp (IBM) 212.12B 19.10 5.97 3.00%
Accenture (ACN) 131.82B 16.31 4.18 2.95%
Infosys (INFY) 48.73B 15.04 4.72 4.36%
Fiserv (FISV) 29.73B -7.56 1.41 0.00%
Cognizant (CTSH) 25.95B 10.59 1.76 2.24%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value51.17 Economic moatNone UncertaintyLow

Trading 23.3% below Morningstar's fair value estimate.

Fair value

Genpact Ltd receives a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 15% discount to our quantitative fair value estimate of $51.17 per share, which is reinforced by this estimate's low uncertainty rating.

The firm's profitability strengthens our estimated valuation. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 9.5%, which falls in the top 30% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.

Conversely, the company's liquidity is potentially concerning. Excessive liquidity may suggest inefficient capital use or limited investment opportunities. The firm's median trading volume over the past 60 days, a core component of liquidity, lies in the top 30% globally. High trading volumes could indicate a sharp change in business model or a new growth trajectory of the business. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Genpact discussion 0 comments

Add a comment